Keith Batchelder, MD, Founder, CEO

Keith Batchelder is the founder and CEO of Genomic Healthcare Strategies, a company focused on the changes in healthcare resulting from advances in molecular medicine. GHS provides strategy and implementation services for companies looking to enter or grow in the new markets emerging as result of predictive diagnostics and preventive medicine. Dr. Batchelder has long been interested in the intersection of the scientific, business and societal promises and challenges raised by personalized medicine. His area of expertise is in the analysis of new markets, channels, partners, and the new science supporting the rapidly evolving practice of medicine and wellness.

During a career that has spanned medical research, clinical practice, and management in start-ups and large organizations, Dr. Batchelder focuses on the practical application of advanced healthcare innovation and its economics. He has served as chief technical officer of WorldCare International Clinical Trials, where he used biomarkers as surrogate endpoints for successful FDA approvals; as CIO of Harvard Salud Integral, where he helped to raise funding and grow a start-up HMO in Mexico City; as a principal of AMICAS Corp, where he took a web-based radiology system from concept to a venture-funded and profitable software company; and at Massachusetts General Hospital for eight years, where as a staff member he conducted industry sponsored research in innovative drug discovery, invented novel techniques and published in peer reviewed journals.

Dr. Batchelder was educated at Middlebury College, the Hahnemann University School of Medicine, received postgraduate training in Medical Informatics at The Boston VA Hospital and completed a fellowship at the Food and Drug Administration. He also holds a masters degree in biomaterials from New York University.

Dr. Batchelder writes and speaks frequently on the topic of personalized medicine (e.g., Nature Biotechnology, Scientific American conference on Targeted Medicine, Burrill & Co, LabCompete, Molecular Medicine Tri-Conference) and has organized several well attended symposia on Personalized Medicine.

Dr. Batchelder, acting on his belief in the potential of personalized medicine, is one of the first ten volunteers to have their full duplex genomes sequenced and published in Harvard Genetics Professor George Church’s Personal Genome Project.